论文部分内容阅读
目的:探讨冠心病合并糖尿病的临床特点治疗体会,为治疗冠心病合并糖尿病临床治疗提供方向。方法:选择2012年2月至2014年2月我院确诊收治的225例患者,其中,单纯冠心病组138例,冠心病合并糖尿病组87例。对两组患者分别完成血糖、血脂、糖化血红蛋白、血压、C-反应蛋白和纤维蛋白原等检测,两组结果进行比较分析。结果:与单纯冠心病组相比较,冠心病合并糖尿病组患者在血糖、血脂、糖化血红蛋白、血压、C-反应蛋白和纤维蛋白原等检测结果和住院病死率等指标上,存在着显著性差异,差异具有统计学意义(P<0.05),且冠心病合并糖尿病组患者多支、C型和末梢病变。结论:冠心病合并糖尿病患者在血糖、血脂、糖化血红蛋白、血压、C-反应蛋白和纤维蛋白原等检测结果与单纯冠心病患者检测结果的差异明显,且住院病死率高,值得广泛关注。
Objective: To explore the clinical features of coronary heart disease with diabetes treatment experience, for the treatment of coronary heart disease with diabetes provide the direction of clinical treatment. Methods: Totally 225 patients diagnosed in our hospital from February 2012 to February 2014 were selected, of whom 138 were diagnosed as coronary heart disease and 87 as coronary heart disease with diabetes mellitus. The two groups of patients were completed blood glucose, blood lipids, glycosylated hemoglobin, blood pressure, C-reactive protein and fibrinogen and other tests, the two groups were compared results. Results: Compared with simple coronary heart disease group, there was a significant difference in the indexes of blood glucose, blood lipid, glycosylated hemoglobin, blood pressure, C-reactive protein and fibrinogen and in-hospital mortality among patients with coronary heart disease and diabetes mellitus , The difference was statistically significant (P <0.05), and multiple coronary artery disease with diabetes mellitus, C-type and peripheral lesions. Conclusion: The results of blood glucose, blood lipid, glycosylated hemoglobin, blood pressure, C-reactive protein and fibrinogen in CHD patients with diabetes mellitus are significantly different from those in CHD patients and the hospital mortality is high, which deserves extensive attention.